Biotech firm Illumina targets net zero emissions by 2050

It has also made a commitment to invest $20m to support initiatives dedicated to sustainable innovation, environmental education, biodiversity research and sustainable agriculture projects

Net Hero Podcast

Illumina, a manufacturer of life science tools and integrated systems for genetic variation and biological function analysis, has announced its target for net zero greenhouse emissions by 2050.

The biotechnology company has set science-based targets across its entire value chain, joined the UN Race to Zero campaign and signed the Business Ambition for 1.5°C.

Its shorter term targets include a 46% emissions reduction from direct operations and a 46% reduction of emissions from its indirect operations by 2030, with a focus on the value chain elements associated with purchased materials, transportation, investments, business travel and employee commuting.

Illumina has also made a commitment to invest $20 million (£14.5m) to support initiatives dedicated to sustainable innovation, environmental education, urban tree planting, biodiversity research and sustainable agriculture projects.

The company will report its net zero progress yearly in its annual report and CDP submission.

Francis deSouza, Chief Executive Officer of Illumin said: “Human health and the health of our environment are intertwined. At Illumina, we are dedicated to making a positive impact on humanity, through the applications of our breakthrough genomics technologies and also through how we operate.

“With our commitment to responsible and sustainable practices, we aim to help shape a more sustainable and equitable future for all.”